19 Jan 2021

Grifols to initiate new Covid-19 drug trial in Spain

Grifols is set to initiate a clinical trial in Spain to analyse a new Covid-19 drug, which can potentially offer immediate post-exposure protection against the SARS-CoV-2 virus. An anti-SARS-CoV-2 immunoglobulin,…

18 Jan 2021

Seelos Therapeutics begins dosing in study of SLS-002

Clinical-stage biopharma firm Seelos Therapeutics has dosed the first patients in its registrational 'Proof of Concept' study to evaluate SLS-002 (intranasal racemic ketamine) for acute suicidal ideation and behaviour in…

18 Jan 2021

Cyxone screens first patient in Phase II Covid-19 trial

Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating Covid-19 patients. The trial is analysing the efficacy and safety…